Lycorine cancer study retracted after image overlap concerns go unanswered
BMC Cancer editors have retracted a 2022 study claiming lycorine blocks tumor blood supply by docking to PDGFRα, citing overlapping ...
BMC Cancer editors have retracted a 2022 study claiming lycorine blocks tumor blood supply by docking to PDGFRα, citing overlapping ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.